期刊文献+

节约基因诱导重塑对治疗2型糖尿病的研究 被引量:1

Study of thrifty genotype on non-insulin dependent diabetes mellitus
下载PDF
导出
摘要 目的 研究诱导方法 (药物的潜伏性 )在 2型糖尿病临床治疗中的作用及与化学药物 (磺脲类 )之间的关系。方法  336例 2型糖尿病患者者随机分成 3组 ,分别为中药组、西药组和中西医结合组 ,定期检测血糖及做胰岛素释放试验。结果 中西医结合组用药 3~ 6个月后 ,出现糖耐量试验右移、餐后 2h血糖正常或接近正常 ;胰岛素释放左移、峰值向 30~ 6 0min靠近。总有效率为 97%。并伴随年龄的增长存在有效性增长的趋势。结论 节约基因诱导重塑可使 2型糖尿病患者血糖调控更趋简单化 。 Objective It is to study the effect of revulsive method (latent quality of medicines) on non insulin dependent diabetes mellitus (NIDDM) and the relationship with medicines. Methods 321 patients were divided into TCM group, western medicine group and integrated group. The plasma glucose was determined terminally as well as sugar tolerance test and the insulin release test were carried out. Results Three to six months later, in the integrated group the peak value of OGTT moved right words, the level of plasma glucose tow hours after food was normal or around normal, the release of insulin moved left wards, the peak value was thirty to sixty minutes. The effective rate of integrated group was 97%. DMBG dosage and Minidlab was reduced and in some cases ceased. The efficiency tended to increase with the age. Conclusion Revulsion and rebuilding of thrifty genotype makes it ease for NIDDM to adjust and control their plasma glucose. The effect of the compounding is superior to that of the separated.
出处 《现代中西医结合杂志》 CAS 2003年第4期339-340,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 节约基因 诱导重塑 糖尿病 thrifty genotype revulsion and rebuilding diabetes mellitus
  • 相关文献

参考文献6

二级参考文献5

共引文献109

同被引文献21

  • 1梁苹茂,甄红晅,范春来,王学文.连梅汤对阴虚热盛证2型糖尿病患者血清C反应蛋白和白细胞介素-6的影响[J].中国中医药信息杂志,2006,13(5):13-14. 被引量:6
  • 2庞铁良,庞秀花.升清降糖方对2型糖尿病患者胰岛素抵抗影响的临床观察[J].北京中医,2006,25(9):546-548. 被引量:2
  • 3朱健萍,巩如伦.益肾活血汤治疗2型糖尿病的临床观察[J].天津中医药,2006,23(5):377-378. 被引量:2
  • 4叶任高,陆再英.6版.内科学[M].北京:人民卫生出版社,2006:799-834.
  • 5World Health Organization. Types of Diabetes[EB/OL]. [2011-04-28]. http://www, who. int/diabetesactiononline/diabetes/basics/en/in dexl. html.
  • 6International Diabetes Federation. Diabetes Atlas (third edition) [S]. Belgium: Hoorens Printing NV, 2007: 36.
  • 7Liu JP, Zhang M, Wang W, et al. Chinese herbal medicines fortype 2 diabetes mellitus[J]. Cochrane Database of Syst Rev, 2004, (3): CD003642.
  • 8Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMAstatement[J]. PLoS Med, 2009,6(7): e10OO097.
  • 9Alderson P, Green S, Higgins J. Cochrane Reviewer's Handbook 4.2.2[updated December 2003][M/OL].[2004-03-20].http://www. cocbrane. org/resources/handbook/hbook, htm.
  • 10Jadad AR, Moore RA, Carroll D. Assessing the quality of reports of randomized clinical trials : is blinding necessary?[J]. Controll Clin Trials, 1996,17(1): 1-12.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部